APA

Cleven A. H. G., Derks S., Draht M. X. G., Smits K. M., Melotte V., Van Neste L., Tournier B., Jooste V., Chapusot C., Weijenberg M. P., Herman J. G., de Bruïne A. P. & van Engeland M. (20151015). CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Cleven Arjen H G, Derks Sarah, Draht Muriel X G, Smits Kim M, Melotte Veerle, Van Neste Leander, Tournier Benjamin, Jooste Valerie, Chapusot Caroline, Weijenberg Matty P, Herman James G, de Bruïne Adriaan P and van Engeland Manon. 20151015. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Cleven A. H. G., Derks S., Draht M. X. G., Smits K. M., Melotte V., Van Neste L., Tournier B., Jooste V., Chapusot C., Weijenberg M. P., Herman J. G., de Bruïne A. P. and van Engeland M. (20151015). CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Cleven Arjen H G, Derks Sarah, Draht Muriel X G, Smits Kim M, Melotte Veerle, Van Neste Leander, Tournier Benjamin, Jooste Valerie, Chapusot Caroline, Weijenberg Matty P, Herman James G, de Bruïne Adriaan P and van Engeland Manon. CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20151015.